[Current and future indications for bendamustine: chronic lymphocytic leukemia, indolent lymphoma, mantle cell lymphoma and diffuse large B-cell lymphomas]

Onkologie. 2013;36 Suppl 1:11-8. doi: 10.1159/000346106. Epub 2013 Jan 28.
[Article in German]
No abstract available

MeSH terms

  • Animals
  • Antineoplastic Agents, Alkylating / administration & dosage
  • Bendamustine Hydrochloride
  • Dose-Response Relationship, Drug
  • Forecasting*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Lymphoma / drug therapy*
  • Nitrogen Mustard Compounds / administration & dosage*

Substances

  • Antineoplastic Agents, Alkylating
  • Nitrogen Mustard Compounds
  • Bendamustine Hydrochloride